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Abstract 
Alkylresorcinols (AR), a group of phenolic lipids present in the outer parts of wheat 
and rye, have been evaluated as biomarkers for the intake of whole grain (WG) 
products of these cereals. AR may be utilized to facilitate the investigation of diet-
disease associations in epidemiological studies. In the body, AR are metabolized to two 
phenolic acids, DHBA and DHPPA, which can be detected in plasma and urine, either 
as such or as more polar conjugates. The aim of this thesis was to evaluate AR 
metabolites DHBA and DHPPA as biomarkers for the intake of WG wheat and rye. 
A gas chromatographic – mass spectrometric method was established that allowed 
the reliable quantification of AR metabolites in urine samples. This method was 
comparable to a previously established HPLC-CEAD method. Plasma 
pharmacokinetics of AR and their metabolites were compared in rats administered 
intact AR orally or AR metabolites intravenously. The elimination was faster for AR 
metabolites than for intact AR and the elimination half-lives increased linearly with the 
number of carbon atoms in the side chain. The formation of metabolites did not differ 
between rats given shorter or longer AR homologues, indicating that the different 
homologues were absorbed to a similar extent. Several anthropometric and dietary 
factors were identified by multivariate statistical tools as potential determinants of 
urinary AR metabolites and were hypothesized to influence the formation and excretion 
of AR metabolites at different stages during AR elimination. The reproducibility and 
relative validity of urinary AR metabolites as biomarkers for the intake of whole grain 
wheat and rye were assessed in Swedish men and women consuming their habitual diet. 
AR metabolites were well correlated to self-reported intakes of WG and cereal fibre. 
The reproducibility of urinary AR metabolites over 2-3 months was dependent on the 
stability of intake and was higher in 24-h urine collections compared to spot samples.  
Due to the scarcity of 24-h urine collections in large observational studies and the 
modest reproducibility in plasma and spot urine samples, the utility of single AR 
metabolite measurements alone to reflect long-term intakes in epidemiological studies 
is limited. However, other applications of AR metabolites as biomarkers might prove 
useful in future studies (e.g., as a compliance check in intervention studies or as 
reference methods in validations of other dietary assessment tools). 
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1 Background 
A high intake of whole grain (WG) has been associated with decreased risk of 
chronic diseases (such as coronary heart disease, diabetes, obesity, and some 
cancers) in several observational studies (McKeown et al., 2012; Mellen et al., 
2008; Priebe et al., 2008; Jensen et al., 2006; Montonen et al., 2003). Although 
the direct mechanisms are largely unknown, the health promoting effects of 
WG consumption are considered to be mainly attributable to the abundance of 
dietary fibre and phytochemicals in cereals (Fardet, 2010). 
Defined by AACC International (formerly known as the American 
Association of Cereal Chemists), "whole grains shall consist of the intact, 
ground, cracked or flaked caryopsis, whose principal anatomical components - 
the starchy endosperm, germ and bran - are present in the same relative 
proportions as they exist in the intact caryopsis”. The main cereals consumed 
as whole grain worldwide are wheat, rice and maize, followed by oats, rye, 
barley, triticale, millet, and sorghum (Fardet, 2010). Among Nordic 
populations, rye is the main source of whole grains in Denmark, Finland, and 
Sweden, while wheat dominates in Norway (Kyro et al., 2011).  
Evaluations of the relationship between diet and disease might be hampered 
due to large diversities between studies in the estimation of WG intake ( e.g., 
WG definitions used, cereals included as WG and inclusion threshold for WG 
content in products to be considered as WG product) (Thane et al., 2005; 
Jensen et al., 2004; Jacobs et al., 1998). 
The compliance and accuracy of intake estimation largely affect the 
assessment of treatment effects in intervention studies and the evaluation of 
diet-disease associations in observational studies respectively. The traditional 
methods of intake estimation are based on self-reports and an example is the 
widely used food frequency questionnaire (FFQ). It offers a cheap estimation 
of long-term intake (Willett, 1998), although the accuracy has been questioned 
(Schatzkin & Kipnis, 2004; Bingham et al., 2003). Other estimation methods, 12 
e.g., food records and recalls, are more expensive and repeated measurements 
are often needed to estimate long-term intake (Willett, 1998). 
The traditional dietary assessment methods suffer from systematic and 
random under and over estimation, due to memory and motivation, which 
together with true intake variation contribute to measurement errors (Fraser, 
2003). To some extent, these errors might be accounted for by calibration to 
‘reference’ methods, e.g., weighed food records (Willett, 1998). However, the 
crucial assumption for such calibration, that the errors of the two methods are 
uncorrelated, is in many cases doubtful (Subar et al., 2003).  
In addition to the aforementioned measurement errors and calibration 
problems, the estimation of WG intake is subjected to additional obstacles. 
Firstly, consumers may encounter difficulties in identifying whole grain 
products and determining the whole grain content in such foods (Kantor et al., 
2001). Secondly, differences between studies in terms of WG definition, 
cereals included as WG, and units used for quantification, complicate study 
comparisons (Frølich & Åman, 2010; Jensen et al., 2004; Lang & Jebb, 2003). 
Finally, the limited number of WG related questions in FFQ in combination 
with a large variation of WG content among cereal products is likely to affect 
the precision of WG intake estimation (Fraser et al., 2005).  
1.1 Dietary  biomarkers 
Dietary biomarkers (DB) are compounds that can be used to reflect the intake 
of certain foods or nutrients. DB represent a less subjective measurement of 
intake than traditional dietary assessment methods, as they are generally not 
subjected to human perception and opinions (Marshall, 2003). Consequently, 
the measurement errors of biomarkers are likely to be independent of those of 
traditional methods. 
Depending on whether the DB correlate to intake or provide quantitative 
measurements of intake, they can be classified in different categories (Kaaks et 
al., 2002). Recovery biomarkers are based on precise and quantitative 
knowledge of the physiological balance between intake and output and offer an 
absolute measurement of a subject’s intake (Kaaks et al., 2002). Examples of 
recovery biomarkers are 24-h excretion of nitrogen, doubly labelled water, and 
potassium as biomarkers for intakes of protein, energy, and potassium, 
respectively (Tasevska et al., 2006; Bingham, 2003; Livingstone & Black, 
2003). Concentration biomarkers are correlated to intake but do not offer a 
quantitative measurement of intake, since they may exhibit diverse quantitative 
relationships with intake between and within individuals (Kaaks et al., 2002). 
Biomarkers of this category can be used to rank individuals and examples 13 
include serum fatty acids and plasma vitamin C and carotenoids as biomarkers 
for intakes of fat and fruit/vegetables, respectively (Bingham et al., 2008; 
Jansen et al., 2004; Wolk et al., 2001). Finally, a third category of dietary 
biomarkers, prediction biomarkers, has been suggested (Tasevska et al., 2005). 
Compared to recovery biomarkers, only a small proportion of the intake can be 
quantified as a biomarker, though the relationship with intake is fairly constant 
between and within individuals. Urinary excretions of sucrose and fructose 
during 24-h were proposed and implemented as prediction biomarkers for 
sugar intake (Tasevska et al., 2011; Tasevska et al., 2005). 
Two key features of DB are their reproducibility and validity. A valid 
biomarker measures what it is intended to do (Kaaks et al., 1997) and 
validation can be reflected by the correlation between biomarker measurement 
and the true intake. Repeated weighed food records may be used as surrogates 
for ‘true’ intake and the correlation between biomarker and surrogate indicates 
the relative validity of the biomarker, which is subjected to measurement errors 
in both the biomarker and the surrogate method, although the measurement 
errors of the surrogate are assumed to be random. 
Reproducibility indicates the correlation between repeated measurements   
within the same individual (Kaaks et al., 1997) and is often assessed by 
calculation of the intra-class correlation coefficient (ICC). The ICC is a 
measure of the proportion of total variation that is due to variation between 
individuals. A high ICC indicates a proportionally small variance over time 
within the same individual compared to the variance between individuals and 
thus a high reproducibility between measurements. A low reproducibility may 
be accounted for by repeated measurements and the reproducibility is 
dependent on the stability of intake (van Dam & Hu, 2008). 
The requirements of the DB are dependent on its purpose. As a surrogate 
measurement of intake, DB can be used in observational studies to investigate 
the associations between diet and disease (Bingham et al., 2008; Key et al., 
2007). To evaluate diet-disease relationship, intake usually needs to be 
assessed over several years, as the time for diseases to develop is typically 
long. Hence the biomarker should preferably reflect long-term intake. For this 
purpose, good reproducibility of the biomarker is crucial, since a reproducible 
biomarker reduces the number of measurements needed to estimate the true 
long-term biomarker level. Recently, the combined use of biomarkers and self-
reports has been proposed as an advantageous tool in the assessment of diet-
disease associations (Freedman et al., 2010a).  
Alternatively, DB can be used to assess compliance in dietary intervention 
studies (Baldrick et al., 2011). Compliance biomarkers are not only useful as 
alternative control tools of compliance but could also act as additional 14 
motivating factors if subjects are aware of biomarker measurements (Ross, 
2012).  
Since the measurement errors of dietary biomarkers can be considered as 
independent compared to those of traditional assessment methods, biomarkers 
may be utilized as ‘reference’ methods for the validation of traditional dietary 
assessment methods (Fraser et al., 2005; Kaaks et al., 1997). However, the 
independence of measurement errors between different methods is a crucial 
assumption in these validations and in most cases it is questionable how well 
this assumption is fulfilled if two methods based on similar methodology (e.g., 
food records and FFQ) are utilized in validation.  
1.2 Alkylresorcinols 
A group of phenolic lipids, alkylresorcinols (AR), have been extensively 
evaluated as biomarkers for the intake of whole grain and bran products of 
wheat and rye (Figure 1). This thesis focuses on the evaluation of AR 
metabolites as novel biomarkers for WG wheat and rye intake to be used as a 
complement or replacement to intact AR.  
   
Figure 1. The five major cereal alkylresorcinol homologues have saturated odd-numbered alkyl 
chains with 17-25 carbon atoms. The trivial names of the homologues are based on the degree of 
saturation and the length of the alkyl chains (C17:0-25:0, top to bottom). 15 
1.2.1 Occurence 
Alkylresorcinols are 1,3-dihydroxy-5-n-alk(en)ylbenzene derivatives found in 
several families of plants, mosses, algae, fungi, and bacteria (Kozubek & 
Tyman, 1999). Due to their antimicrobial activities observed in vitro, AR have 
been suggested to be involved in the plants’ defence system (Stasiuk & 
Kozubek, 2010; Kozubek & Tyman, 1999).  
Table 1. Content of AR in cereal grains, bran, and WG products of rye and wheat.
1 
  Range 
(µg/g
2)
 
Reference 
Rye    
Grains
3  568-1441  (Shewry et al., 2010; Ross & Kochhar, 2009; Andersson et al., 
2008a; Kulawinek et al., 2008; Landberg et al., 2008; Ross et al., 
2001) 
Bran 1266-4108  (Ross & Kochhar, 2009; Kulawinek et al., 2008; Mattila et al., 2005; 
Chen et al., 2004) 
WG bread  197-707  (Ross & Kochhar, 2009; Kulawinek et al., 2008; Mattila et al., 2005; 
Chen et al., 2004; Ross et al., 2003c) 
Crisp bread  490-1007  (Chen et al., 2004; Ross et al., 2003c) 
Wheat
4    
Grains
3   138-1429  (Ross & Kochhar, 2009; Andersson et al., 2008a; Kulawinek et al., 
2008; Chen et al., 2004; Ross et al., 2003c; Hengtrakul et al., 1990) 
Bran 2211-2672  (Kulawinek et al., 2008; Chen et al., 2004; Ross et al., 2003c) 
WG bread  142-608  (Ross & Kochhar, 2009; Kulawinek et al., 2008; Chen et al., 2004; 
Ross et al., 2003c) 
White bread  26-47  (Ross & Kochhar, 2009) 
Crisp bread  58-420  (Chen et al., 2004; Ross et al., 2003c) 
Durum wheat    
Grains
3 54-751  (Andersson et al., 2008a; Landberg et al., 2006a; Ross et al., 2003c) 
WG Pasta  40-435  (Ross & Kochhar, 2009; Landberg et al., 2006a; Chen et al., 2004) 
    
1AR, Alkylresorcinol; WG, whole grain
. 2Dry matter. 
3Includes grains and whole gra meal.
 4Includes grains and 
WG meal.
  4 Includes common (Triticum aestivum), einkorn (Triticum monococcum), emmer (Triticum 
dioccon), and spelt wheat (Triticum spelta). 
5The upper limit of the range was obtained by analyzing 125 
samples of common wheat grown in different locations.   
Among commonly consumed plants, AR are only abundantly present in wheat 
(Triticum Spp.) and rye (Secale cereale) (Table 1). Although triticale contains 
AR (Gohil et al., 1988; Radcliffe et al., 1981) and small amounts of AR (<210 
µg/g) are present in barley (Andersson et al., 2008b; Chen et al., 2004; 
Zarnowski & Suzuki, 2004; Ross et al., 2003c; Zarnowski et al., 2002), the 
contribution to dietary AR is negligible due to the limited consumption of these 16 
cereals. In addition, very small content of AR has been reported in other food 
materials (e.g., maize, garden peas, mango, and animal fat) (Jansson et al., 
2010; Knoedler et al., 2009; Gembeh et al., 2001; Kozubek & Tyman, 1999). 
Although the content of AR in cereals is highly heritable, it is also affected by 
the environment (Andersson et al., 2010). 
Cereal alkylresorcinols are predominantly present as saturated derivatives 
with odd-numbered alkyl chains ranging from 17-25 carbon atoms (Ross et al., 
2003a) (Figure 1). However, unsaturated, keto, and hydroxy derivatives have 
also been found, especially in rye (Knodler et al., 2007; Ross et al., 2004a; 
Kozubek & Tyman, 1999; Seitz, 1992). The trivial names of the different AR 
derivatives indicate, similar to fatty acids, the chain length and degree of 
saturation (e.g., C17:0).  
AR in the cereal kernel are exclusively located in the outer parts (Ross et 
al., 2001; Tluscik, 1978), more precisely in the outer cuticulum of testa/inner 
cuticulum of pericarp (Landberg et al., 2008). Therefore, bran and whole grain 
products of wheat and rye contain AR (Table 1), while they are absent or found 
in very small concentrations in refined products (Ross & Kochhar, 2009; 
Mattila et al., 2005; Chen et al., 2004).  
1.2.2 Absorption 
The suggested main route of AR absorption consists of uptake at the small 
intestine and incorporation into chylomicrons, which are transported via the 
lymphatic system from enterocytes to the systemic circulation (Linko-Parvinen 
et al., 2007). Direct high-density lipoprotein (HDL) efflux from enterocytes to 
the portal vein has been observed for tocopherols in vitro and might be a 
complementary absorption pathway for AR (Anwar et al., 2006). The fraction 
absorbed in this way would potentially be exposed to hepatic metabolism 
before entering the systemic circulation. 
The apparent absorption of AR in humans has been investigated by 
measuring the content of AR in ileal effluent from ileostomy-operated patients 
and was determined to about 60% (Ross et al., 2003a). There were, however, 
large differences between patients (45-71%) and homologues with shorter-
chains were seemingly absorbed to a larger extent than the longer-chained 
homologues (i.e., disappeared to a greater extent). The apparent absorption in 
pigs was similar to humans (Ross et al., 2003b). Absorption might be lower in 
rats, which were observed to fecally excrete 61% of the given dose, mainly as 
unchanged AR (Ross et al., 2003b). However, this percentage might under-
estimate absorption, since it accounts for unabsorbed AR and possibly also 
absorbed AR excreted in bile. 17 
1.2.3 Distribution 
Absorbed AR in plasma are mainly (70-80%) found in lipoproteins and among 
them, HDL and very-low-density lipoprotein are the main carriers of AR 
(Linko-Parvinen et al., 2007). In contrast, no AR are present in the plasma 
water (Linko-Parvinen et al., 2007). It has been suggested that AR, after 
entering the systemic circulation from lymph, are transported in chylomicrons 
to the liver where they are redistributed to very-low-density lipoprotein and 
HDL. These lipoprotein particles are subsequently secreted back to the 
circulation.  
The amphiphilic nature of AR enables them to be incorporated in biological 
membranes (Stasiuk & Kozubek, 2010). A substantial proportion of AR in 
blood are located in erythrocytes and concentrations in erythrocytes correlate 
well with plasma concentrations (Linko-Parvinen et al., 2007; Linko & 
Adlercreutz, 2005). Longer AR homologues are more easily incorporated into 
the erythrocyte membranes compared to shorter homologues (Linko & 
Adlercreutz, 2005).  
In addition, AR were observed in adipose tissue from free-living individuals 
(Jansson et al., 2010) and habitual intake might lead to accumulation in other 
tissues. 
1.2.4 Metabolism 
Since intact AR have not yet been found in bile and only minute amounts have 
been quantified in urine (Ross et al., 2004b), an extensive metabolism of AR is 
responsible for their rather fast elimination from plasma, with elimination half-
life (t½) of about five hours (Landberg et al., 2006b). The metabolism of AR is 
hypothesized to share similarities with tocopherol metabolism. In fact, AR 
were found to competitively inhibit γ-tocopherol metabolism in vitro and AR 
increased hepatic γ-tocopherol levels in rats (Ross et al., 2004c). Like 
tocopherols, the biotransformation of AR includes both oxidative metabolism 
(phase I) and conjugation reactions (phase II). 
Phase I metabolism 
During phase I metabolism, polar functional groups are introduced or 
unmasked in lipophilic compounds to enhance excretion or  allow conjugation 
reactions (Gibson & Skett, 2001). Phase I reactions include oxidation, 
reduction, and hydrolysis, which are mediated by several enzyme families 
(Gibson & Skett, 2001; Timbrell, 1999). The suggested phase I metabolism of 
AR shares similarities with the metabolism of other phenolic lipids e.g.,   
tocopherols (Sontag & Parker, 2002; Birringer et al., 2001), Vitamin K 
(Shearer & Barkhan, 1973), and nonylphenol (Thibaut et al., 2000). 18 
Phase I metabolism of tocopherols is initiated by ω-oxidation, which is 
mediated by Cytochrome P450 isoenzyme CYP4F2 (Sontag & Parker, 2007; 
Sontag & Parker, 2002). This microsomal enzyme is expressed in liver and 
kidney (Hirani et al., 2008) and has diverse functions, e.g., Vitamin K1 oxidase 
(McDonald et al., 2009). The carboxylated intermediary tocopherol 
metabolites resulting from the ω-oxidation is activated to an acyl-CoA ester 
and the activated tocopherol metabolite undergoes subsequent β-oxidation 
(Birringer et al., 2001). Through β-oxidation, side chains are gradually 
shortened, finally leading to the formation of carboxymethylbutyl-
hydroxychroman and carboxyethyl-hydroxychroman end-products (Birringer et 
al., 2001).  
Since AR inhibit tocopherol oxidation, it is likely that ω-oxidation of AR is 
mediated by CYP4F2 (Ross et al., 2004c). As the shorter-chained homologue 
C15:0 is more effective in inhibiting tocopherol ω-oxidation compared to a 
mixture of homologues, it is possible that CYP4F2 prefers to hydroxylate 
short-chained homologues (Ross et al., 2004c). However, the weaker inhibition 
caused by the AR mixture could partly reflect analytical artifacts caused by 
solubility issues in the in vitro system. 
The major metabolites of AR, 3,5-dihydroxybenzoic acid (DHBA) and 3-
(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA), are two phenolic acids first 
discovered in human urine after consumption of WG wheat (Ross et al., 
2004b). Their formation represents, together with the competitive inhibition of 
tocopherol ω-oxidation, the strongest evidence of the proposed pathway for AR 
metabolism (Figure 2). Similar to their tocopherol equivalents (carboxyethyl-
hydroxychromans and carboxymethylbutyl-hydroxychromans), the smaller AR 
metabolite (DHBA) is the theoretical result of an additional β-oxidation cycle 
of its precursor (DHPPA). 
Phase II metabolism 
During phase II metabolism, polar groups are conjugated to xenobiotics or 
endogenous compounds to increase excretability. Like phase I metabolism, 
specific enzymes catalyze the conjugation reactions and several factors can 
influence the activity of these enzymes, e.g., anthropometry, genes, diet, and 
life style (Harris & Waring, 2008; Williams et al., 2002; Liston et al., 2001). 
Glucuronidation and sulfation are the two major phase II metabolic 
pathways during which AR, their end-products, and possible intermediate 
metabolites could be conjugated. During glucuronidation a sugar moiety is 
covalently bound to endogenous compounds, xenobiotics, or their metabolites 
(Zamek-Gliszczynski et al., 2006). 19 
 
Figure 2. Suggested metabolic pathway of the major cereal AR (n=1-5). Ω-oxidation of AR 
results in carboxylated alkylchains, which are activated and subsequently shortened by several 
cycles of β-oxidation. The end-products of β-oxidation are hydrolysed to the two major AR 
metabolites, DHBA and DHPPA. The dashed arrow indicates several cycles of β-oxidation. In 
addition to this phase I metabolism, conjugation with glucuronic and sulfonic acids increases the 
hydrophilicity and thereby simplifies excretion. 20 
The process is catalyzed by UDP-glucuronyltransferases which use uridine 
diphosphate glucuronic acid as co-substrate and different isoforms of the 
enzyme are found in the endoplasmic reticulum of different tissues, although 
the liver is the major site for glucuronidation (de Leon, 2003; McGurk et al., 
1998).In addition to glucuronidation, other glycosylations with different co-
substrates may contribute to phase II metabolism. For example, the major 
metabolite of γ-tocopherol in mouse urine was identified as γ-carboxyethyl-
hydroxychroman  β-D-glucoside (Cho et al., 2009).  
Sulfation of xenobiotics is catalyzed by several human cytosolic 
sulfotransferases with diverse substrate specificity (Hashiguchi et al., 2011; 
Coughtrie et al., 1998). Several sulfotransferases were shown to exert diverse 
activities towards different tocopherols and tocopherol metabolites (Hashiguchi 
et al., 2011). Sulfortransferases uses 3’-phosphoadenosine-5’-phosphosulfate 
as a co-substrate to covalently bind sulfonic acid to hydroxyl or amine groups 
of the substrate (Strott, 2002).  Due to the fast depletion of co-substrate, 
sulfation is considered a low capacity phase II reaction (Zamek-Gliszczynski et 
al., 2006).  
Although the phrasing might be misleading, phase II metabolism does not 
necessarily need to be preceded by phase I metabolism. Intact AR were found 
in very small amounts in human urine, however only after incubation with 
deconjugating enzymes β-glucuronidase and sulfatase. This indicates that 
conjugation reactions can occur on intact AR and that phase I and phase II 
metabolism of AR might occur in parallel, similar to what has been proposed 
for tocopherols (Hashiguchi et al., 2011; Freiser & Jiang, 2009; Jiang et al., 
2007). Both UDP-glcucuronyltransferase and cytochrome P450 isoenzymes 
(e.g., CYP4F) are microsomal proteins and might use AR as substrates 
(Sanders et al., 2008; Nyquist & Morre, 1971). 
Although no conjugated AR have been observed in plasma, AR metabolites 
are extensively found as conjugates in plasma (Koskela et al., 2008). It is 
possible that AR metabolites function as better substrates for conjugating 
enzymes than their precursors (Hashiguchi et al., 2011) or that conjugated AR 
are metabolized to conjugated DHBA and DHPPA within the metabolizing 
cells before secretion to plasma. 
1.2.5 Excretion 
As end-products of AR metabolism, 3,5-dihydroxybenzoic acid (DHBA) and 
3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA) are eliminated from the 
body by excretion (Ross et al., 2004b). The elimination of AR metabolites has 
been suggested to be slower than AR elimination (Soderholm et al., 2011; 
Soderholm et al., 2009; Landberg et al., 2006b). If true, this would indicate 21 
that AR metabolite concentrations are less affected by the time between intake 
and measurement; an advantageous feature of a dietary biomarker. However, 
estimations of AR metabolite elimination were conducted by measuring 
concentrations in plasma and urine after consumption of rye bread and not by 
administration of pure DHBA and DHPPA (Soderholm et al., 2011; Soderholm 
et al., 2009). Consequently, the half-lives reported, defined as the time required 
for a 50% reduction of maximum concentration (or excretion rate), may not 
exclusively reflect the elimination of AR metabolites, but also AR absorption 
and metabolism. Hepatically formed AR metabolites could theoretically exit 
the body in faeces (via bile) or urine and thereby complete the route of AR 
absorption, distribution, metabolism and excretion (Figure 3). 
 
Figure 3. The suggested fate of ingested alkylresorcinols. For more detailed information, see text. 
In brief, ingested alkylresorcinols are absorbed in the small intestine and transported in 
chylomicrons via the lymphatic system (1) and/or via direct HDL transfer from the intestine 
through the portal vein and liver to the systemic circulation (2). Absorbed alkylresorcinols are 
carried in plasma lipoproteins and erythrocytes (3). From the systemic circulation, AR can be 
distributed to other body compartments, e.g. adipose tissue (4). In the liver, alkylresorcinols can 
be reassembled in lipoproteins (5) and secreted back to the circulation or metabolized to two 
phenolic acids by CYP450 mediated ω-oxidation and several cycles of β-oxidation (6). In 
addition, phase II metabolism results in the formation of conjugated metabolites (7). The 
metabolites can be secreted to the systemic circulation (8) and subsequently renally excreted (9). 
Biliary secretion (10) represents another excretion route of AR metabolites, which can 
theoretically be reabsorbed in the intestine (11) to complete enterohepatic circulation. Ingested 
AR appear eventually, as such or as metabolites, in urine (12) and faeces (13). 
Biliary excretion 
So far, no studies have reported biliary excretion of AR or their two major 
metabolites, DHBA and DHPPA. However, DHBA and DHPPA were recently 
quantified in ileostomy effluent from four subjects consuming rye bran and 20-
25% of the ingested dose was present as the two AR metabolites, 
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predominantly as DHPPA (unpublished data). In addition, DHPPA has been 
identified in bile from pigs (Rikard Landberg, personal communication, March 
14, 2012). This indicates the important role of biliary excretion in AR 
elimination. Consumption of sesame seeds increased the biliary excretion of 
intact  γ-tocopherol in rats, probably by inhibiting the the ω-hydroxylating 
enzyme (Yamashita et al., 2000). In a similar way, it is possible that the 
inhibition of metabolizing enzymes could induce or increase biliary excretion 
of intact AR. The plasma concentration profile of AR metabolites after a single 
dose of AR indicates that biliary excreted AR metabolites could be absorbed in 
the intestine and thereby they would be subjected to enterohepatic circulation, 
which might be repeated (Soderholm et al., 2009). This would prolong the time 
that AR metabolites reside within the body. Finally, it is possible that biliarly 
excreted AR metabolites are further degraded by intestinal microbiota before 
arriving in faeces (Griffiths & Smith, 1972). 
Urinary excretion 
When rats were given a single radiolabelled dose of AR, 31% of the 
radioactivity was recovered in urine (Ross et al., 2003b). The urinary excretion 
of intact AR is very minor and the fraction of ingested AR to finish up in urine 
is due to the excretion of DHBA and DHPPA (Ross et al., 2004b). Of the two 
metabolites, DHPPA is more abundant in urine and both metabolites are 
present as free aglycones and conjugates (Landberg et al., 2009a; Koskela et 
al., 2007).  
The proportion of ingested AR that is excreted as DHBA or DHPPA in 
urine decreases with an increasing dose (Landberg et al., 2009a). This 
phenomenon might be attributable to a decreased absorption at higher intake 
levels. This was observed in pigs fed breads containing different amounts of 
AR (Ross et al., 2003b). However, the difference in apparent absorption could 
also be due to differences in experimental breads regarding fibre content and 
botanical fractions used. A dose-dependent shift in elimination has been 
proposed as an alternative explanation of the decreased urinary recovery 
(Landberg et al., 2009a). According to this, the proportion of AR metabolites 
excreted in urine would decrease at higher intakes of AR, while other, 
alternative elimination routes would become more predominant. The increased 
biliary elimination of tocopherols at higher intakes supports this idea (Kiyose 
et al., 2001). Furthermore, since AR-containing foods are rich in dietary fibre, 
a high AR intake is accompanied by a high fibre intake. High fibre diets might 
decrease deconjugation of biliarly excreted AR metabolites and thereby 
suppress enterohepatic circulation (Adlercreutz, 2010). This would decrease 
the amounts of AR metabolites available for renal excretion. Finally, DHBA 23 
and DHPPA from other potential sources might, to a small extent, over-
estimate the urinary recovery, especially at low AR intakes. 
1.3  Analysis of AR metabolites 
Several analytical methods have been utilized to quantify AR concentration in 
plasma, such as gas chromatography-mass spectrometry (GC-MS) (Landberg 
et al., 2009b; Linko et al., 2002), gas chromatography/tandem mass 
spectrometry (Nagy et al., 2008), and liquid chromatography/tandem mass 
spectrometry (Ross et al., 2010). So far, the quantification of AR metabolites 
has only been performed by high performance liquid chromatography- 
coulometric electrode array detection (HPLC-CEAD)(Koskela et al., 2008; 
Koskela et al., 2007).  
The presence of conjugated DHBA and DHPPA in plasma and urine 
indicates the necessity of deconjugation prior to quantification (Koskela et al., 
2008; Koskela et al., 2007). Deconjugation is commonly performed by 
incubation with hydrolysing enzyme preparations, which can target specific 
conjugates or deconjugate several different conjugates, e.g., β-glucuronidase 
from Helix pomatia does not only deconjugate glucuronides and glucosides 
(Cho et al., 2009) but also possesses sulfatase activity.  
Quantifications of urinary AR metabolites by HPLC-CEAD have been 
preceded by sample pre-treatments of diverse degree (Soderholm et al., 2011; 
Aubertin-Leheudre et al., 2010b; Aubertin-Leheudre et al., 2010c; Aubertin-
Leheudre et al., 2008; Guyman et al., 2008; Koskela et al., 2007); from direct 
urine analysis to deconjugation and subsequent sample clean-up (including 
liquid-liquid and solid phase extractions). Plasma DHBA and DHPPA have 
been quantified after deconjugation, acidification and repeated liquid-liquid 
extraction (Aubertin-Leheudre et al., 2010a; Aubertin-Leheudre et al., 2010b; 
Aubertin-Leheudre et al., 2010c; Soderholm et al., 2009; Koskela et al., 2008). 
Deconjugations of plasma and urinary AR metabolites have been performed by 
simultaneous incubation with two separate enzymes (β-glucuronidase and 
sulfatase). Both methods have utilized syringic acid as the internal standard. 
Although the sample preparation in some cases is quick, the analytical run 
time of HPLC-CEAD is rather extensive (Weckwerth, 2007) and when 
analyzing AR metabolites, the time between two injections exceeds one hour. 
This is considerably longer than the run-time of the GC-MS methods used for 
the quantification of intact AR (Landberg et al., 2009b; Linko et al., 2002), 
which is less than 30 minutes. The tedious analysis limits the sample 
throughput and hinders quantification of large sample sets. In addition, gas 
chromatography offers a greater number of theoretical plates than liquid 24 
chromatography (Moldoveanu & David, 2002), which can be beneficial for 
peak separation. In fact, the interference of co-eluting compounds has 
prevented the quantification of urinary DHBA under some conditions (Guyman 
et al., 2008). 
1.4  AR metabolites as biomarkers 
1.4.1 Specificity 
Even though urinary excretion of DHBA and DHPPA is strongly related to the 
intake of WG rye and wheat, small amounts of dietary AR in refined cereal 
products and bran-enriched foods might contribute to AR metabolite 
concentration in plasma and urine (Ross & Kochhar, 2009). Nevertheless, low 
concentrations (<7.1 µmol/L) of both AR metabolites have been detected in 
urine from celiac patients, with diets assumingly free from AR (Koskela et al., 
2007). This could be due to patients not complying with a diet excluding 
wheat, rye and barley or to analytical artefacts e.g., co-elution of interfering 
compounds (Guyman et al., 2008). However, there might be alternative 
sources of DHBA and DHPPA, not related to AR.  
Table 2. Reported content of DHBA in different food and beverages. 
Sample Concentration  Reference 
Peanuts
1 4-16  µg/g  (Reddy et al., 1977) 
Beer 0.21±31  mg/L  (Floridi et al., 2003) 
Wort   0.35±60 mg/L  (Floridi et al., 2003) 
Green tea  trace  (Gruz et al., 2008) 
Chickpeas n/a
2  (Khadem & Marles, 2010) 
Raspberries n/a
2  (Khadem & Marles, 2010) 
Rhubarb n/a
2  (Medynska & Smolarz, 2005; 
Smolarz et al., 2005) 
1Occurrence in peanuts is uncertain since the only reference reporting it classifies α-resorcylic acid as a 
monohydroxybenzoic acid. 
2No amounts or concentrations were reported. 
Although phenolic acids are abundant in nature, reported identifications of 
derivatives with two hydroxyl groups in meta positions to the carboxylic side 
chain are scarce (Ross et al., 2004b). However, DHBA (or alternatively α-
resorcylic acid) has been described as a constituent in different foods, food 
materials, and beverages (Table 2). In addition to the foods and beverages 
listed in Table 2, DHBA has been found in Horseweed (Conyza canadensis), 
Rosa roxburghii, and Rhizobium sp. isolated from Sesbania procumbens 
(Sridevi et al., 2008; van Rensburg et al., 2005; Mukhtar et al., 2002).  25 
On the contrary, DHPPA has not been found in foods or beverages but has 
been reported as a metabolite of sinapic acid and flavonoids in rats and rabbits 
(Table 3). The amounts of DHPPA reported are generally small and the 
degradation of the precursors to DHPPA is thought to be mainly attributable to 
intestinal microbiota (Takagaki & Nanjo, 2010; Griffiths & Smith, 1972; 
Griffiths, 1970). Additionally, olivetol (a short-chain alkylresorcinol) has been 
found to be microbially degraded to DHPPA (McClanahan & Robertson, 
1984). Since the intake of olivetol is very limited, it will probably not 
contribute to DHPPA concentrations in plasma and urine from individuals 
consuming their habitual diet. 
Table 3. Identification of DHPPA in animals after consumption of sinapic acid and flavanoids  
Precursor Specie  Sample  Amount  Reference 
Sinapic acid  Rabbit  Urine  Major metabolite  (Griffiths, 1970) 
 Rat  Urine  Not reported  
 Rat  Intestinal 
microflora 
Not reported  
Tricetin Rat  Urine  Small  amounts  (Griffiths & Smith, 1972) 
 Rat  Intestinal 
microflora 
Not reported  
Tricin Rat  Urine  3.1%  of  dose  (Griffiths & Smith, 1972) 
 Rat  Intestinal 
microflora 
Small amounts   
5,7 – Dihydroxy-3',4',5'-
trimethoxyflavone 
Rat  Urine  Traces  (Griffiths & Smith, 1972) 
Epigallocatechin gallate  Rat  Intestinal 
microflora 
Minor amounts  (Takagaki & Nanjo, 2010) 
 
1.4.2  Reproducibility and validity 
Few studies have assessed the reproducibility of plasma and urinary AR 
metabolites in free-living subjects so far (Landberg et al., 2012b; Montonen et 
al., 2012). The reproducibility of plasma metabolites was evaluated by 
analyzing plasma samples obtained from 100 German participants on two 
separate occasions, 4 months apart (Montonen et al., 2012). The calculated 
ICC values of DHBA and DHPPA indicated substantial within-person 
variability of AR metabolites in plasma. Similar results were observed after the 
quantification of AR metabolite concentration in spot urine samples obtained 
from American women on two occasions, 1-3 years apart (Landberg et al., 
2012b). In both studies, DHPPA showed higher reproducibility than DHBA. 26 
Several studies report good responsiveness of AR metabolites in plasma and 
urine to intakes of AR, WG rye and wheat, rye and cereal fibre (Aubertin-
Leheudre et al., 2010c; Landberg et al., 2009a; Aubertin-Leheudre et al., 2008; 
Guyman et al., 2008). In a Swedish dose-response study, increases in AR 
intake by 100% and 300% caused 24-h AR metabolite excretion to rise by 62% 
and 149% respectively (Landberg et al., 2009a). Correspondingly, fasting 
plasma concentrations of AR increased by 42% and 207% respectively. Among 
American participants, consumers of WG wheat and rye excreted 72% more 
DHPPA than non-consumers (Guyman et al., 2008). Additionally, a serving 
increase in WG wheat and rye increased 12-h urinary DHPPA excretion by 
94% after adjustment for BMI and intakes of energy and fibre. In another 
study, American female health professionals’ intakes of WG and cereal fibre 
(assessed by FFQ) were generally correlated to AR metabolite concentration in 
spot samples (Landberg et al., 2012b). Self-reported rye intake among Finnish 
women was correlated to 24-h urinary excretion (P<0.001) and fasting plasma 
concentration (P<0.05) of AR metabolites (Aubertin-Leheudre et al., 2010c). 
Similarly, the intake of cereal fibre in the same group of women was correlated 
to AR metabolites in plasma and urine (P<0.001) (Aubertin-Leheudre et al., 
2008).  
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2  Aims of this thesis 
The aim of this thesis is to evaluate the applicability of AR metabolites as 
biomarkers for the intake of whole grain wheat and rye. In order to achieve 
this, several objectives were determined and are listed below. 
 
1.  To develop a gas-chromatographic mass-spectrometry method for the 
quantification of AR metabolites in urine (I).  
 
2.  To compare the developed gas-chromatographic mass-spectrometry 
method with a previously published high-performance liquid-
chromatographic coulometric electrode array detector method (II). 
 
3.  To evaluate AR and metabolite pharmacokinetics in rats and compare 
metabolite formation of different AR homologues (III). 
 
4.  To identify potential determinants of AR metabolite excretion and 
conjugation pattern in urine from free-living individuals and to evaluate 
the relative validity of different urinary conjugates of DHBA and 
DHPPA (IV). 
 
5.  To assess the relative validity and medium-term reproducibility of 
urinary AR metabolites in free-living individuals consuming their 
habitual diet (V). 
  28 
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3  Materials and methods 
3.1  Reference compounds and enzymes 
The reference compounds and derivatizing reagents used in studies I-V are 
listed in Table 4.  
Table 4. Reference compounds and derivatization reagents used in the different studies. 
Trivial name  Supplier  Purity  Study 
Alkylresorcinols      
C17:0
1  Reseachem Lifescience, Burgdorf, Switzerland.  >95%  III 
C25:0
2  Reseachem Lifescience, Burgdorf, Switzerland.  >95%  III 
Metabolites      
DHBA
3  Sigma-Aldrich Chemie, Steinheim, Germany.  >97%  I-V 
DHPPA
4  Isosep, Tullinge, Sweden.  >95%  I-V 
Internal standards      
C20:0
5  Reseachem Lifescience, Burgdorf, Switzerland.  >95%  III 
DHPAA
6  Apin Chemicals, Abingdon, UK.  >98.5%  I 
Syringic acid  Sigma Chemicals, St. Louis, MI, USA.  >98%  I-V 
Derivatizing reagents      
BSTFA
7  Thermo Scientific, Rockford, IL, USA.  -  I-II, IV-V 
MSTFA
8  Sigma Chemicals, St. Louis, MI, USA  -  I 
QSM
9  Pyridine (Merck, Darmstadt, Germany), 
hexamethyldisilazane (Supelco, Bellafonte, PA, 
USA), and trimethylchlorosilane (Supelco, 
Bellafonte, PA, USA) 
-  I, III 
15-n-Heptadecylresorcinol. 
25-n-Pentacosylresorcinol. 
33,5-dihydroxybenzoic acid. 
43-(3,5-dihydroxyphenyl)-
propanoic acid. 
55-n-Eicosylresorcinol. 
63,5-dihydroxyphenylacetic acid. 
7N,O-bis-(trimethylsilyl)-trifluoro-
acetamide with 1% trimethylchlorosilane.
8N-methyl-N- (trimethylsilyl)trifluoroacetamide.
 9 Quick silylation 
mixture (self-prepared). 30 
3.2  Chromatographic analysis of AR and their metabolites 
The methods and instrumentation for the analysis of AR in plasma and their 
metabolites in plasma and urine are listed in Table 5. In study I, a gas 
chromatography – mass spectrometry (GC-MS) method was developed for the 
analysis of AR metabolites in urine (Table 5). The parts of the method 
developed within this thesis (indicated as bold in Table 5) are addressed in 
separate sections below. Apart from the optimization of sample deconjugation, 
the method development involved the evaluation of different internal standards 
and derivatization procedures. The GC-MS method developed in paper I was 
used to quantify urinary AR metabolites in studies II, IV, and V. In addition, 
high performance liquid chromatography - coulometric electrode array 
detection (HPLC-CEAD) was utilized to quantify urinary DHBA and DHPPA 
in paper II and the quantified concentrations were compared to those 
determined by GC-MS. Plasma AR and their metabolites in paper III were 
analyzed by a modification of a previously published GC-MS method for the 
quantification of human plasma AR (Landberg et al., 2009b) and the method 
described in paper I. In the same study, the basal rat diet was analyzed for AR 
content by a previously published gas chromatography method (Ross et al., 
2001). Control samples were included in each analytical batch to evaluate the 
precision of the analyses. In papers I, II, and V the control samples were 
individual 24-h collections from subjects consuming different amounts of AR 
and thereby had a diverse AR metabolite concentration. The control samples in 
paper IV were pooled urine of 24-h collections from 24 individuals consuming 
their habitual diet. Pooled fasting plasma from six individuals was used as a 
control sample in paper III.  
3.3 Deconjugation 
In order to quantify the total concentration of AR metabolites or to determine 
the amounts of different conjugates, urine and plasma samples were incubated 
with deconjugating enzymes prior to quantification. In the first paper, urine 
was incubated with different concentrations of a crude mixture of Helix 
pomatia enzymes, containing β–glucuronidase and sulfatase activities, and a 
pure  β–glucuronidase to optimize deconjugation. In the same study, urine 
samples from nine individuals participating in an intervention study and 
consuming equal amounts of AR were incubated with optimized concentrations 
of the two different enzyme solutions and with a pure buffer (without 
enzymes).  31 
Table 5. Methods and instrumentation for the quantification of AR and their metabolites in 
biological samples. 
Study II  I-II,  IV-V  III 
Method HPLC-CEAD
1 GC-MS
2 GC-MS
2 
Analyte  AR metabolites  AR metabolites  AR and their 
metabolites 
Matrix  Urine Urine Plasma 
Sample volume  50 µl  50 µl   50 µl  
Internal 
standard
3 
Syringic acid  Syringic acid  C20:0
4 
Syringic acid
5 
Incubation 
volume
6,3 
750 µl  750 µl  265 µl  
Post-incubation 
acidification 
15 µl HCl  15 µl HCl  100 µl CH3COOH  
Liquid-liquid 
phase extraction 
2× 3 ml ethyl acetate  2× 3 ml ethyl acetate  3× 3 ml diethyl ether 
Solid-phase 
extraction
2 
Mixed mode (anion 
exchange/reversed 
phase) 
Mixed mode (anion 
exchange/reversed 
phase) 
Mixed mode (anion 
exchange/reversed 
phase) 
Derivatization
3  -  Silylation 1 h with 
100µl BSTFA
7 at 
60˚C. 
Silylation 1 h with 
50µl QSM
8 at 60˚C. 
Injection volume  10 µl
9  1.5 µl  1.5 µl 
Separation  Gradient elution 
delivered by LC-10AD 
pumps (Shimadzu 
Corporation, Japan). 
Temperature gradient 
in Trace Ultra GC 
(Thermo Fischer 
Scientific, USA). 
Temperature gradient 
in Trace Ultra GC 
(Thermo Fischer 
Scientific, USA). 
Column  Inertsil ODS-3 (3× 150 
mm) 
BP-5 (30 m×0.25 
µm×0.25 mm). 
BP-5 (30 m×0.25 
µm×0.25 mm). 
Detector  CEAD
1 (ESA 
Biosciences) 
Mass: Trace DSQ II 
(Thermo Fischer 
Scientific, USA).  
Mass: Trace DSQ II 
(Thermo Fischer 
Scientific, USA).  
Detection  Retention times and 
peak area ratios 
Molecular ions  Molecular ions 
Quantification  Area ratio of analyte 
and internal standard. 
Multi-point calibration 
curves. 
Area ratio of analyte 
and internal standard. 
Multi-point calibration 
curves.. 
Area ratio of analyte 
and internal standard. 
Multi-point calibration 
curves.  
1High performance liquid chromatography - coulometric electrode array detection. 
2Gas chromatography-mass 
spectrometry. 
3Step evaluated in study I. 
4For quantification of AR. 
5For quantification of AR metabolites. 
6Samples were incubated with a sodium acetate buffer (pH 5) containing deconjugating enzymes. 
7N,O-
bis(trimethylsilyl)trifluoroacetamide with 1% trimethylchlorosilane. 
8Quick silylation mixture. 
9One third of 
extracts were evaporated to complete dryness after solid-phase extraction and reconstituted in 50 µl MeOH and 
100 µl mobile phase.  32 
The quantified concentrations were compared to assess the abundance of free 
and conjugated AR metabolites in urine. Similarly, in paper IV urine samples 
from 51 individuals consuming their habitual diets were incubated with and 
without pure β–glucuronidase or sulfatase in order to assess the amounts and 
proportions of free and conjugated urinary AR metabolites. The enzymes used 
to deconjugate AR metabolites are listed in Table 6. 
Table 6. Enzymes
1 used for deconjugation of conjugated AR metabolites. 
Enzyme Type  Origin  Activity  Study 
Mixture H-1  Helix pomatia  β-Glucuronidase  I-V 
     Sulfatase   
β-Glucuronidase B-1  Bovine  liver  β-Glucuronidase  I, IV 
Sulfatase V Patella vulgata  Sulfatase  IV 
1All enzymes were purchased from Sigma Chemicals (St. Louis, MI, USA).  
3.4  Study design and samples 
3.4.1 Human  studies 
Samples and subjects of the different studies are listed in Table 7. Ninety one 
volunteers (70 women and 21 men) in the Uppsala area were recruited to a 
study with the aim of investigating the reproducibility of plasma AR and 
urinary AR metabolites and their relative validity as biomarkers for the intake 
of whole grain rye and wheat. The participants, aged 20-70 with no diagnosed 
or perceived gastro-intestinal disease or symptoms, were instructed to adhere to 
their habitual diet and to complete a three-day weighed food record (3DWFR) 
on two occasions, approximately 2-3 months apart. On the last day of each 
recording, the participants performed a 24-h urine collection and collected 25 
ml of morning urine in a separate tube. Volumes of 24-h collections were 
recorded and aliquots of 50 ml were kept together with morning urine samples 
at -80°C until analysis. Spot samples of morning urine were analyzed for 
creatinine to enable adjustment for diuresis. The 24-h urine collections were 
used in papers I, II, IV, and V, while the morning urine samples were only 
analyzed in paper V.  
Apart from the 24-h urine collections screened for endogenous excretion of 
the two internal standard candidates, syringic acid and 3,5-dihydroxyphenyl 
acetic acid (DHPAA), urine samples from nine individuals, with equal AR 
intakes, participating in an intervention study were analyzed in paper I to 
determine the abundance of conjugated AR metabolites in urine. 33 
Table 7. Human urine samples analyzed in the different studies. 
Study  Female 
(n) 
Male 
(n) 
Inclusion criteria  Samples 
analyzed (n) 
Sample selection 
I 17 3 General
2. 40  Random 
I
1 5  4 Not available  10  Similar amounts men 
and women with 
equal AR intake  
II 43  16  General
2. 114  Random 
IV 34  18 General
2. Complete 24-h 
urine collection and 
3DWFR
3 on the first 
occasion. FIL
4 ≥ 1.08 if 
6DWFR
5 were available and 
FIL
4 ≥ 1.00 if only 3DWFR
3 
were available. BMI < 30. 
52  All men available and 
the first women 
recruited  
V 50  16  General. Complete 24-h 
urine collection, morning 
urine spot sample, and 
3DWFR
3 on both occasions. 
FIL
4 ≥ 1.08. 
132 All  samples
6 
1Urine from 9 individuals with equal AR intakes participating in an intervention study (Landberg et al., 2009a) 
were analyzed after incubation with different enzymes. 
2Recruited participants were 20-70 years old and were 
not diagnosed with or perceived to have gastric-intestinal disease or symptoms.
3Three-day weighed food 
records. 
4Food intake level (FIL=daily energy intake/basal metabolic rate). 
5Six-day weighed food records. 
624-h collections and spot samples of morning urine.
 
3.4.2 Rat  study 
In paper III, 7-8 week-old male Sparauge-Dawley rats were acclimatized (10 
days) before they were put on an AR-free diet based on corn starch. After two 
weeks on the diet, catheters were surgically attached to the femoral artery and 
vein. On the day following surgery, rats were infused during 30 min with saline 
solutions containing DHBA or DHPPA at three different concentrations. Blood 
samples were preferably drawn through an artery catheter approximately 0, 15, 
28, 60, 90, 210, and 390 mins. after infusion start. Another group of 7-8 week-
old male Sprague Dawley rats were acclimatized for 17 days before kept on the 
AR-free diet for two weeks. These rats were not subjected to surgery and were 
administrated with corn oil supplemented with three different amounts of AR 
homologues C17:0 or C25:0 by gavage. Similar to the intravenous infused AR 
metabolites, twelve rats per substance were divided equally on the three dose 
levels. Blood was drawn 0, 3, 6, 12, 24, and 36 hours after gavage. Plasma was 
immediately separated from blood and kept at -80°C until analysis.  
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3.5 Pharmacokinetics 
Pharmacokinetic parameters were non-compartmentally calculated from 
plasma concentration curves in paper III using Microsoft Office Excel 2007 
(Microsoft Corporation, Redmond, WA, USA). In addition, population 
pharmacokinetic models of the individual substances (C17:0, C25:0, DHBA, 
and DHPPA) were developed using NONMEM 7.2 (Icon, Leopardstown, 
Ireland). One, two, and three-compartment models were evaluated and 
different residual error models were tested. Model diagnostics were performed 
with Xpose 4 (Jonsson & Karlsson, 1999) and model evaluation was done in 
PSN (Lindbom et al., 2005; Lindbom et al., 2004). 
3.6 Statistical  analysis 
All statistical analyses were performed using SAS version 9.1 (SAS Institute 
Inc., Cary, NC, USA), unless otherwise stated. 
3.6.1 Method  development 
Differences between derivatization reagents were evaluated using a mixed 
linear model with derivatization reagent, analyte, and post-derivatization 
procedure as fixed factors and replicate as random factor. In addition, least-
squares means were calculated for derivatization reagents and P-values were 
Bonferroni-corrected. Temperature dependence of quick silylation mixture 
incubation was also evaluated by a mixed linear model with temperature and 
analyte as fixed factors and replicate as random factor. Finally, least-means 
squares were calculated for temperatures. 
3.6.2 Method  comparison 
The agreement between quantifications by GC-MS and HPLC-CEAD was 
evaluated by the graphical investigation of difference-plots (Bland & Altman, 
1986) and by weighted Deming regression analysis (Linnet, 1990). Difference-
plots are useful tools to display differences between methods, but do not 
provide statistical tools for inference of the differences. The weighted Deming 
regression analysis is suitable if measurement errors are proportional and the 
procedure accounts for errors in both methods (Linnet, 1993). In this case, 
samples were not analyzed in replicates and equality of variance between the 
two methods was assumed. Analyse-it version 2.22 (Analyse-it Software 
Ltd.,Leeds, UK) and Microsoft Office Excel 2007 (Microsoft Corporation, 
Redmond, WA, USA) were used for weighted Deming regression analysis and 
difference-plots. 35 
3.6.3  Comparison of pharmacokinetic parameters 
In paper III, differences in body weight and calculated pharmacokinetic 
variables between AR and their metabolites were evaluated by mixed linear 
models with substance and dose level as fixed factors. Least-squares means 
were calculated for substances. 
3.6.4  Conjugated urinary AR metabolites 
A general linear model was used in paper I to compare the relative excretion of 
conjugated urinary AR metabolites between metabolites and sexes. In this 
model, metabolite and sex were fixed factors while subject was set as a random 
factor. In paper IV, the differences in conjugation between AR metabolites 
were evaluated by paired t-tests. Paired t-tests were also used to estimate the 
presence of conjugates other than sulfoconjugates or glucuronides. Differences 
between the sexes in the excretion of free and conjugated urinary AR 
metabolites were evaluated by t-tests. 
3.6.5  Possible determinants of urinary AR metabolites 
In paper IV, possible dietary or anthropometric determinants of urinary AR 
metabolites were identified by multivariate data analysis. Dietary factors 
(intake of WG and macro and micronutrients) estimated by 3DWFR, were 
energy-adjusted by the nutrient density method (Willett & Stampfer, 1998). 
Principal component analyses were separately performed on intake and 
excretion to observe potential clusters of individuals and relationships between 
dietary components or excretion. In order to find possible determinants of 
urinary AR metabolites partial least squares (PLS) regression was used. The 
initial PLS models included numerous dietary and anthropometric factors and 
the regression analysis was performed in a step-wise manner where low-impact 
parameters were removed until models with minimum root-mean-square error 
of predictors were obtained. Findings from PLS analyses were confirmed by 
step-wise regression analyses using general linear models. Unscrambler 10.1 
(CAMO, Oslo, Norway) was utilized for principal component and PLS 
analyses. 
3.6.6  Proportion of dose recovered in urine 
The recovery was defined as the amount of ingested AR that was excreted as 
DHBA and DHPPA in urine (paper V). AR intake was estimated as the mean 
daily intake of two 3DWFR and excretion was calculated as the mean 
excretion in two 24-h urine collections. A general linear model was utilized to 
calculate  P  for trend, where the log-transformed metabolite recovery was 36 
dependent variable and the quartile median AR intake was independent 
variable. 
3.6.7 Reproducibility 
The medium-term (2-3 months) reproducibility of urinary AR metabolite 
excretion was assessed by calculating the intra-class correlation coefficient 
(ICC). In paper V, ICC were calculated for AR metabolites in 24-h urine 
collections and morning urine spot samples, as well as for self-reported intakes 
of macronutrients, WG, and AR. The ICC and their 95% CI were calculated by 
a freely available SAS macro (Hertzmark & Spiegelman, 2010). 
3.6.8 Relative  validity 
The relative validity of urinary AR metabolites as biomarkers for the intake of 
WG wheat and rye was assessed by correlating self-reported intakes among 
free-living participants with their excretion of AR metabolites. In paper IV, the 
relative validities of 24-h urinary excretions of free, conjugated, and total AR 
metabolites as biomarkers of WG intake were evaluated by calculating 
Spearman’s rank correlation coefficients (rs) between self-reported intake, 
estimated by a 3DWFR, and AR metabolite excretion. Similarly, rs between 
self-reported WG and fibre intakes and urinary AR metabolites (24-h excretion 
and creatinine adjusted metabolite concentration in morning spot samples) 
were calculated in paper V. In this study, rs were calculated between self-
reported intake and AR metabolites in urine on the same occasion and 2-3 
months apart. Additionally, rs of intake and excretion were calculated between 
separate occasions and their mean. The observed rs were separately adjusted 
for intra-individual variance in intake and metabolite excretion. Finally, rs were 
calculated between 24-h excretions and creatinine-adjusted AR metabolite 
concentrations in spot samples of morning urine.  37 
4  Results and discussion 
4.1  Quantification of AR metabolites 
AR in plasma have been analyzed by GC-MS (Landberg et al., 2009b; Linko et 
al., 2002), gas chromatography/tandem mass spectrometry (Nagy et al., 2008), 
and liquid chromatography/tandem mass spectrometry (Ross et al., 2010). 
Although AR metabolites were first identified using thin layer chromatography 
and GC-MS (Ross et al., 2004b), HPLC-CEAD have been utilized for their 
quantification in urine and plasma (Koskela et al., 2008; Koskela et al., 2007). 
Analysis with GC-MS has several advantages (e.g. specificity, relatively short 
run-time and high number of theoretical plates, which allows better separation) 
and the equipment is more commonly available in laboratories than HPLC-
CEAD systems. Therefore, one aim of this thesis was to develop a GC-MS 
method for AR metabolites (I) and to compare it with HPLC-CEAD (II).  
4.1.1  GC-MS method development 
In the HPLC-CEAD method, syringic acid was used as the internal standard for 
the quantification of AR metabolites (Koskela et al., 2007). Syringic acid is a 
phenolic acid and thus shares some structural similarities with DHBA and 
DHPPA, which is an important feature of internal standards. Another potential 
internal standard for the quantification could be 3,5-dihydroxyphenyl acetic 
acid (DHPAA), the structural intermediate to DHBA and DHPPA. However, 
both candidate compounds have been identified in biological samples; syringic 
acid is present in a number of cereal products (Mattila et al., 2005) and small 
concentrations have been found in urine after berry-rich meals (Nurmi et al., 
2009), while DHPAA was present in rat urine after oral administration of 
myrecetin and related compounds (Griffiths & Smith, 1972). In paper I, 
endogenous concentrations of syringic acid and DHPPA in urine from free-
living individuals were found to be ≤ 3.5 µmol/L and ≤ 4.4 µmol/L, 38 
respectively. The upper limit of detector linearity was higher for syringic acid 
(0.225 nmol/injection) than DHPAA (0.150 nmol/injection), which allows a 
higher amount of syringic acid to be used as the internal standard. In the final 
protocol, syringic acid was selected as the internal standard due to a narrower 
range of endogenous concentration in combination with a higher upper limit of 
detector linearity. The amount of syringic acid added to each sample (15 nmol) 
was approximately 100 times higher than the endogenous amounts in screened 
samples, though well within the range of detector linearity. 
Derivatization with N,O-bis(trimethylsilyl)trifluoroacetamide yielded larger 
peak areas (P<0.02) than silylation with N-methyl-N-
(trimethylsilyl)trifluoroacetamide or quick silylation mixture. The injection of 
silylated reference compounds re-dissolved in hexane yielded in peak areas 1-
10% of the peak areas resulting from injection directly after derivatization. 
Thus, injection directly after derivatization with N,O-
bis(trimethylsilyl)trifluoroacetamide was selected in the final protocol.  
The presence of AR metabolites conjugated to sulfonic and/or glucuronic 
acid in urine has been shown in previous studies (Koskela et al., 2007). In 
order to quantify the total amounts of DHBA and DHPPA, urine samples were 
incubated with deconjugating enzymes that catalyze the hydrolysis of 
conjugates, thus creating homogeny of AR metabolites. The deconjugation 
procedure was optimized in paper I, where urine was incubated with different 
concentrations of pure β-glucuronidase (which catalyzes hydrolysis of 
glucuronides) and a crude mixture of Roman snail (H. pomatia). The mixture 
possesses β-glucuronidase, β-glucosidase, and sulfatase activities and thereby 
enables deconjugation of glucuronides, glucosides, sulfoconjugates, and 
sulfoglucuronides. After incubation with both pure enzyme and enzyme 
mixture, quantified AR metabolite concentrations increased with increased 
enzyme concentrations up to 0.5 mU β-glucuronidase per µl urine. No increase 
in DHBA and DHPPA was observed at higher enzyme concentrations. In the 
final protocol the enzyme mixture was selected as it can deconjugate a wider 
range of possible conjugates and since incubation with the enzyme mixture in 
fact resulted in higher AR metabolite concentrations compared to incubation 
with pure enzyme. 
The limit of quantification, accuracy and precision of the developed GC-
MS method were satisfactory (Table 8) and detection was not considerably 
affected by co-eluting compounds (Figure 4). 39 
 
Figure 4. Chromatograms of urine analyzed for AR metabolites by gas chromatography – mass 
spectrometry. (A) Total ion count (TIC: m/z 50-600) ( B) m/z 370; ( C) m/z 398 and ( D) m/z 
342. Peaks: (1) DHBA, (2) DHPPA, (3) syringic acid and (4) 3,4-dihydroxybenzoic acid. 
Table 8. Performance of the GC-MS method described in study I. 
Parameter DHBA  DHPPA 
Limit of quantification [µmol/L]
1 <0.02
2 0.1 
Accuracy [%]
3 94  93 
Intraassay CV [%]
4 4.9±1.4  7.6±1.2 
Interassay CV [%]
5 5.7±2.5  9.3±4.1 
1The limit of quantification was estimated as the concentration resulting in a signal-to-noise ratio of 10:1. 
2The 
signal-to-noise ratio at the lowest tested concentration, 0.019 µmol/L, was 194:1.
3Determined as the slope of 
the linear regression between the measured and theoretical concentrations of spiked urine. 
4Intraassy CV 
(mean±SD) was determined from the intraassay CV of three occasions. 
5Interassy CV (mean±SD) was 
determined as the standard deviation of mean concentrations from three occasions divided by the mean 
concentration of all occasions. 40 
 
Figure 5. HPLC-CEAD chromatogram of a deconjugated and extracted human urine sample. A: 
Whole chromatogram with all eight channels, B: Detailed part of A with six channels covering 
the elution of DHBA, DHPPA and syringic acid. Due to co-eluting compounds, detection of 
DHBA on the dominant channel (670 mV) (1) was impaired and therefore quantification was 
performed using the peak area on the channel immediately before the dominant channel (600 mV) 
(2). No apparent interference due to co-elution was observed for DHPPA (3) and syringic acid 
(4). 
4.1.2 HPLC-CEAD 
The quantification of DHBA by HPLC-CEAD suffered from problems due to 
the co-elution of interfering compounds. These interferences were worse when 
samples were analyzed directly after deconjugation, and could be suppressed 
by sample extraction and purification (by solid phase extraction) although not 
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completely (Figure 5). Similar obstacles with co-eluting compounds have been 
reported previously (Guyman et al., 2008), which indicates the need for sample 
purification prior to analysis. 
4.1.3 Method  comparison 
In paper II, the GC-MS method developed in paper I was compared to a 
previously published HPLC-CEAD method (Koskela et al., 2007). The same 
protocol was followed for sample pre-treatment (e.g. internal standard, 
enzymatic deconjugation, and two-step extraction), with differences being only 
in chromatography and detection. To allow comparisons of results from studies 
applying different quantification methods, deconjugated and extracted urine 
samples were analyzed by GC-MS and HPLC-CEAD to detect differences 
between methods. 
Graphical inspection of the difference-plot and weighted Deming regression 
analysis showed that urine samples analyzed by HPLC-CEAD resulted 
constantly in higher concentrations of DHBA (0.9 µmol/L) than when analyzed 
by GC-MS (Figure 6). DHPPA concentrations quantified by the two methods 
differed also, but in this case the difference was both additive (intercept: 1.6 
µmol/L higher concentration by GC-MS) and proportional (slope: 10% lower 
concentration by GC-MS). Although these differences were significant, their 
practical implications are probably negligible in most cases. The additive 
differences were <10% than the median concentrations in this study and the 
proportional difference in DHPPA concentrations was of the same magnitude 
as the analytical imprecision reported for the two published methods. However, 
caution should be advised when comparing results from studies analyzed by 
different methods if studies are performed in populations where the intake of 
AR-containing foods is minor. 42 
 
Figure 6. Difference-plots and weighted Deming regressions of alkylresorcinol metabolites in 
human urine. In the difference-plots of DHBA (A) and DHPPA (B), the differences between the 
two methods (GC-MS values subtracted from HPLC values) were plotted against the mean 
concentrations shown by the two methods. The mean differences are shown (solid lines), as are 
the limits of agreement (broken lines), corresponding to mean  ±2 SD. Concentrations quantified 
by GC–MS and HPLC–CEAD are plotted against each other (dots) for DHBA (C) and DHPPA 
(D) and the weighted Deming regressions (DHBA: y =−0.93 + 0.92x and DHPPA: y = 1.64 + 
0.90x) are indicated (unbroken lines), as are the identity lines (broken lines). Outliers excluded 
from the models are shown as crosses. 
4.2  Formation and elimination of AR metabolites 
4.2.1  Absorption, distribution and elimination in rats 
A 1-compartment pharmacokinetic model with two absorption compartments 
has previously been used to adequately predict plasma AR concentrations in 
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humans (Landberg et al., 2009a). Unlike humans, rats (III) and pigs (Linko et 
al., 2006) do not display two maxima of plasma concentration, which indicates 
interspecies differences in absorption. However, these differences could also be 
influenced by the different matrices used for dosing.  
In paper III, plasma concentrations of orally distributed C17:0 and C25:0 
were fitted to 1-compartment models. The formation of AR metabolites did not 
differ between rats orally fed AR homologues C17:0 or C25:0, which shows 
that the different homologues were absorbed to a similar degree. However, the 
formation of metabolites during the first 6 hours was greater in rats given 
C17:0 than in rats consuming C25:0 (P<0.05). This was due to a faster 
elimination of C17:0 (t½≈6 h) than C25:0 (t½≈11 h) (P<0.05).  
The faster elimination of C17:0 might be due to a greater activity of 
metabolizing enzymes toward shorter AR homologues as been previously 
proposed (Ross et al., 2004c) or a greater ability of longer homologues to be 
incorporated into biological membranes (Linko & Adlercreutz, 2005). The 
major metabolite of orally administered AR was DHPPA and no difference in 
the metabolite proportions was observed between rats given C17:0 and C25:0. 
Plasma concentrations of intravenously administered AR metabolites were best 
described by 2-compartment models, where AR metabolites were rapidly 
distributed from the central compartment. The elimination half-lives of DHBA 
and DHPPA (76 mins and 110 mins respectively) were significantly shorter 
than intact AR and the half-lives increased linearly with the length of the side 
chain (P for trend<0.001) (Figure 7). The faster elimination of AR metabolites 
compared to intact AR is probably due to the greater urinary excretability of 
metabolites, whereas intact AR are eliminated mainly by metabolism (Ross et 
al., 2004b; Ross et al., 2003b).  44 
 
Figure 7. Elimination half-lives of AR (C17:0 and C25:0) and their metabolites (DHBA and 
DHPPA) in rat plasma. The elimination half-lives increased linearly with the number of carbon 
atoms in the side chain (P<0.001). The equation of the linear regression between half-life and 
chain length is indicated in the figure. Error bars represents standard errors of estimates. 
4.2.2  Conjugated AR metabolites in human urine 
Unlike DHBA and DHPPA, AR have not yet been identified in plasma as 
conjugates, possibly due to an inability of hepatocytes to excrete conjugated 
alkylphenols to plasma (Daidoji et al., 2003). The very small amounts of 
conjugated AR identified in human urine could be the result of renal 
conjugation and subsequent urinary excretion (Ross et al., 2004b). 
A major part of urinary AR metabolites are present as conjugates resulting 
from phase II metabolism of AR and/or their metabolites (Koskela et al., 2007; 
Ross et al., 2004b) (papers I and IV). Glucuronides were found to be the most 
abundant type of conjugates (papers I and IV). Unlike sulfotransferases, UDP-
glucuronyltransferases are able to conjugate carboxylic groups, thus the 
number of potential forms of AR metabolite glucuronides is greater than the 
number of potential forms of sulfoconjugates (Sakaguchi et al., 2004; Strott, 
2002). In addition, the subcellular localization of the conjugating enzymes 
might affect the proportions of DHBA and DHPPA. If conjugation is not 
exclusive subsequent to terminal β-oxidation, the amphiphilic AR and possible 
intermediary metabolites might be less subjected to cytosolic sulfotransferases  
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Figure 8. Potential determinants of AR metabolites in urine that were suggested to affect AR 
metabolite formation and elimination in different ways: conjugation catalyzed by UDP-
glucuronyltransferases (UGT) and sulfotransferases (ST), endogenous deconjugation by β-
glucuronidase (β-G), Phase I metabolism of AR (Phase I), reabsorption of biliarly excreted AR 
metabolites (Reabsorption), and urine flow. Potential determinants are listed in italics after their 
suggested sites of effects.  
than to microsomal UDP-glucuronyltransferase (Chapman et al., 2004; Nyquist 
& Morre, 1971).  
Compared to DHBA, a greater percentage of DHPPA was glucuronidated 
(P<0.01), while the proportions of other conjugates were similar between the 
two AR metabolites. Incubation with the enzyme mixture resulted in higher 
quantified DHPPA concentrations than summarized concentrations of free, 
glucuronidated and sulfoconjugated DHPPA, which indicated the presence of 
DHPPA conjugated with both glucuronic and sulfonic acid (i.e., 
sulfoglucuronides). Similarly, sulfoglucuronides were identified as urinary 
metabolites of rats intravenously injected with resorcinol, although 
glucuronides were the major metabolites (Kim & Matthews, 1987). The 
presence of sulfoglucuronidated DHPPA and the lack of similar conjugates of 
DHBA could be due to diverse activities of conjugating enzymes toward the 
two phenolic acids, comparable to what has been observed in vitro for different 
tocopherol metabolites (Hashiguchi et al., 2011). 
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Table 9. Potential determinants of AR metabolites in urine and their hypothesized role of action 
Determinant Suggested  influence  Reference 
Age CYP
1 enzyme activities decrease with age  (Bebia et al., 2004; 
Schmucker, 2001) 
BMI  β-glucuronidase activity increases with BMI  (Maruti et al., 2010) 
Sex  Higher activity of UGT
2 among men  (Tanaka, 1999) 
    
Water  Increases urinary excretion rate of glucuronides   
Whole grain 
wheat 
Wheat AR are poorer substrates for CYP
1 
enzymes compared to rye AR. 
(Ross et al., 2004c) 
Protein  Increases phase I metabolism  (Boullata & Armenti, 2010) 
Vitamin C  Decreases UGT
2 activity  (Liu et al., 2000; Sikic et al., 
1977) 
  Vitamin C rich foods increase β-glucuronidase 
activity  
(Maruti et al., 2008) 
  Flavanoids from vitamin C rich foods inhibit 
UGT  
(Williams et al., 2002) 
Vitamin E  Competes for the same phase I enzymes as AR
3 (Ross et al., 2004c) 
  Increases expression of metabolizing enzymes  (Mustacich et al., 2009) 
Calcium  Increases expression of sulfotransferases  (Higashi et al., 2004) 
Magnesium  Less effective β-oxidation in subjects with low 
intake  
(Hisanaga et al., 2004) 
Potassium  Increases urine flow  (Murai et al., 2010; Bannink 
et al., 1999) 
Sodium  Increases co-substrate abundance for 
sulfotransferases 
(Lucke et al., 1981) 
1Cytochrome P450. 
2UDP-glucuronyltransferease. 
3Alkylresorcinol. 
The proportion of urinary AR metabolites conjugated with glucuronic acid was 
higher (P<0.001) in males (n=18) compared to females (n=34), while no 
difference in conjugation between the sexes was observed in the limited 
number of subjects (5 women and 4 men) in paper I. The potential 
determinants were suggested to act in several different organs involved in the 
elimination of AR (Figure 8 and Table 9). A possible explanation of the 
observed sex difference might be a higher activity of the glucuronidating 
enzyme UDP-glucuronyltransferase in men compared to women (Tanaka, 
1999) or a faster phase I metabolism among women (Frank et al., 2008). Apart 
from the sex difference, PLS analyses identified a number of potential 
determinants of AR metabolites in urine. Some determinants were 
hypothesized to affect conjugating and deconjugating enzymes (BMI, sex, 
vitamin C, calcium, and sodium), while others may have influenced phase I 
metabolism (age, protein, vitamin C, magnesium, and WG wheat) and thus 47 
altered the substrate availability for phase II enzymes. In addition, other 
variables extracted from the PLS analyses were theorized to affect the urine 
flow (potassium and water). 
Together with other factors, such as the genetic polymorphism of 
Cytochrome P450 enzymes affecting tocopherol metabolism (Bardowell et al., 
2010), the determinants listed in Table 9 might influence the elimination of AR 
and their metabolites. Hence, they could alter the relationship between AR 
intake and metabolite concentrations in plasma or urine and thereby have an 
impact on the performance of AR metabolites as biomarkers for the intake of 
WG wheat and rye. 
4.2.3  Proportion of dose recovered in urine 
The recovery of urinary AR metabolites is a measure of the proportion of 
ingested AR that terminates as metabolites in urine. The recovery decreased 
with increasing intake in free-living Swedes: participants in the quartile with 
the lowest AR intake (median: 34 µmol/d) had the highest recovery (mean: 
92%), while for participants in the highest intake quartile (median: 148 
µmol/d) the mean recovery was only 53% (Figure 9). These numbers might be 
over-estimations of recovery as minor AR derivatives (e.g., unsaturated 
homologues), not included in the calculation of AR intake, possibly share 
catabolic pathways with the major homologues and therefore could be 
precursors of parts of the urinary AR metabolites. Since rye contains 
substantial amounts of the minor homologues (Ross et al., 2004a) and rye was 
the major source of AR in paper V, it is likely that considerable amounts of the 
minor derivatives were consumed and subsequently metabolized to DHBA and 
DHPPA, which were excreted in urine. Previously, higher amounts of ingested 
AR have resulted in lower proportions recovered as metabolites in urine 
(Landberg et al., 2009a). In the same study AR concentrations in fasting 
plasma increased by 42% and 207% when AR intake was increased by 100% 
and 300% respectively. This indicates a dose-dependent absorption which 
might be reflected by decreasing urinary recovery. Supporting this, the 
apparent absorption in pigs decreased with increased dose, though this could 
also be due to effects of experimental breads in terms of fibre content and 
botanical fractions used (Ross et al., 2003b). On the other hand, decreasing 
urinary recovery might also be due to a dose-dependent shift in elimination, 
from urinary excretion at low doses to biliary at higher doses (Landberg et al., 
2009a). This phenomenon has been observed for tocopherols (Kiyose et al., 
2001; Yamashita et al., 2000).  
In addition, the high fibre content of AR-rich foods dilutes the intestine 
content and thereby reduces the concentration of deconjugating enzymes 48 
(Adlercreutz, 2010). This might decrease the proposed enterohepatic 
circulation of AR metabolites (Soderholm et al., 2011) and consequently 
reduce the proportion available for urinary excretion. Finally, intakes of other, 
potential, non-AR related sources of DHBA and DHPPA might cause over-
estimation in the proportion of ingested AR recovered as DHBA and DHPPA 
in urine at low AR intakes.  
 
Figure 9. Recovery of daily alkylresorcinol (AR) intake as 24-h urinary excretion of AR 
metabolites: 3,5-dihydroxybenzoic acid (DHBA) and 3-(3,5-dihydroxyphenyl)-propanoic acid 
(DHPPA), and their total. Participants that consumed AR and provided 24-h urine collections plus 
acceptable three-day weighed food records on both occasions were included (n = 62) and divided 
into quartiles based on AR intake. The quartile recoveries (geometric means) were plotted against 
median intake per quartile. Error bars represent 95% CI of mean recoveries.  
4.3  AR metabolites as biomarkers 
4.3.1 Reproducibility 
Reproducibility is a crucial parameter of a dietary biomarker and indicates the 
stability of the biomarker within a subject over a period of time. In the case of 
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urinary AR metabolites, reproducibility is a measure of how stable the 
excretion of DHBA and DHPPA is within a subject over a period of time.  
The reproducibility of 24-h excretion of AR metabolites over 2-3 months 
(ICC = 0.48; 95% CI: 0.30-0.66) was moderate (paper V) and similar to the 
reproducibility of AR intake and concentration in fasting plasma from the same 
participants (Andersson et al., 2011). Plasma AR concentration in German 
women also showed a similar reproducibility over four months (Montonen et 
al., 2010). In comparison to 24-h excretions, AR metabolite concentration in 
spot samples of morning urine had lower reproducibility (ICC=0.36; 95% CI: 
0.19-0.58), probably due to the shorter excretion interval. The slightly higher 
ICC values of DHPPA compared to DHBA in both 24-h urine collections and 
spot samples of morning urine probably originates from a more diverse 
DHPPA excretion between participants as indicated by wider 95% confidence 
intervals. The same phenomenon, with lower reproducibility of DHBA in 
comparison to DHPPA, has been observed in spot urine samples from 
American women (Landberg et al., 2012b) and in plasma from German 
individuals (Montonen et al., 2012). The reproducibility of DHPPA in spot 
urine samples was only slightly lower in the American subjects, in spite of 
great diversities between the studies in regard to WG consumption and time 
period evaluated. However, the reproducibility of DHBA was considerably 
higher in the Swedish subjects, which could originate from a higher, more 
stable, and (between individuals) more diverse AR intake among the Swedish 
participants. It could also be partly attributable to the shorter time period 
evaluated. Additionally, unstable intakes of other potential precursors of 
urinary DHBA could attenuate reproducibility, especially if intake of AR-
containing foods is low. In fact, the total consumption of peanuts, a potential 
source of DHBA (Khadem & Marles, 2010; Reddy et al., 1977), increased 
about 10% in the US in the period between urine collections (American Peanut 
Shellers Association, 2011). An increased intake of a potential DHBA source 
(e.g., peanuts) over the time assessed might be partly responsible for the poor 
reproducibility of urinary DHBA observed in the American women. 
Reproducibilities of AR intake and AR, DHBA, DHPPA concentrations or 
amounts in biological samples from different populations over diverse time 
periods are listed in Table 10. The rather fast elimination of AR and their 
metabolites implies that reproducibility over longer time periods is dependent 
on the stability of intake (van Dam & Hu, 2008).  50 
Table 10. Reproducibility of alkylresorcinols and their metabolites in subjects consuming habitual diets.  
 Sample      Subjects         
 Type  Replicates  Period  Country  N
1 Females  ICC
2 (95% CI)  Reference 
Alkylresorcinols  3DWFR  2  2-3 mo  Sweden  72  76%  0.46 (0.26, 0.66)  (Andersson et al., 2011) 
  Fasting plasma  2  1-3 y  Sweden  36  100%  0.73 (0.56, 0.85)  (Landberg et al., 2012a) 
  Fasting plasma  2  4 mo  Germany  100  50%  0.42 (0.25, 0.72)  (Montonen et al., 2010) 
  Fasting plasma  2  2-3 mo  Sweden  51  80%  0.47 (0.27, 0.67)  (Andersson et al., 2011) 
  Fasting plasma  3  3 d  Sweden  18  61%  0.60 (0.36, 0.80)  (Andersson et al., 2011) 
  Non-fasting plasma  3  3 d  Sweden  18  61%  0.18 (0.03, 0.62)  (Andersson et al., 2011) 
DHBA  Spot urine
3  2  1-3 y  USA  104  100%  0.17 (0.05, 0.43)  (Landberg et al., 2012b) 
  24h urine  2  2-3 mo  Sweden  66  76%  0.46 (0.28, 0.65)  Paper V 
 Spot  urine
3  2  2-3 mo  Sweden  66  76%  0.32 (0.15, 0.56)  Paper V 
  24h urine  3  3 d  Sweden  18  61%  0.63 (0.39, 0.81)
4 (Marklund  et al., unpublished data) 
 Spot  urine
3  3  3 d  Sweden  16  69%  0.67 (0.43, 0.84)
4 (Marklund  et al., unpublished data) 
  Plasma  2  4 mo  Germany  100  50%  0.23 (-0.05, 0.48)  (Montonen et al., 2012) 
DHPPA Spot  urine
3  2  1-3 y  USA  104  100%  0.31 (0.17, 0.51)  (Landberg et al., 2012b) 
  24h urine  2  2-3 mo  Sweden  66  76%  0.51 (0.34, 0.68)  Paper V 
 Spot  urine
3  2  2-3 mo   Sweden  66  76%  0.37 (0.19, 0.59)  Paper V 
  24h urine  3  3 d  Sweden  18  61%  0.68 (0.46, 0.85)
4 (Marklund  et al., unpublished data) 
 Spot  urine
3  3  3 d  Sweden  16  69%  0.65 (0.40, 0.83)
4 (Marklund  et al., unpublished data) 
  Plasma  2  4 mo  Germany  100  50%  0.33 (0.06–0.56)  (Montonen et al., 2012) 
1Number of subjects. 
23-day weighted food record; DHBA, 3,5-dihydroxybenzoic acid; DHPPA, 3-(3,5-dihydroxyphenyl)-propanoic acid; ICC, intra-class correlation coefficient 
3Spot samples of morning urine. 
4Evaluated at two occasions and only the lowest value is shown here.  51 
In populations where the intake of AR is quantitatively and temporally stable 
within individuals and covers a wide range between individuals, the 
reproducibility of AR and their metabolites in biological samples can be 
expected to be high. Spot samples, unlike 24-h collections, are not only 
affected by the stability of intake between days, but also sensitive to the 
duration between consumption and collection within the day.  
Plasma AR concentrations are logically more stable under intervention 
conditions where intake is controlled than under free-living conditions and the 
high reproducibility indicates that the number of measurements needed to 
evaluate compliance is very low (Landberg et al., 2009c). The reproducibility 
of AR metabolites in intervention studies has not yet been assessed.  
4.3.2 Relative  validity 
The 24-h excretion of DHBA and DHPPA was significantly correlated to self-
reported intakes of WG wheat and rye, WG rye and cereal fibre, irrespective of 
when intake and excretion were measured (Figure 10). Metabolite 
concentrations in spot samples of morning urine were also correlated to the 
same intake parameters, although only consistently correlated when intake and 
excretion were measured concurrently. The total intake of WG was in general 
only correlated to urinary AR metabolites when measured on the same 
occasion. Although correlations were weaker compared to cereal fibre, the 
intake of total fibre was correlated to 24-h excretion independently of the time 
of measurement and correlated to morning urine metabolites when intake and 
urine were measured concurrently.  
The relative validity of individual conjugates and free aglycones of urinary 
AR metabolites were assessed in paper IV.  In general, correlation coefficients 
of WG intake and individual free aglycones or conjugates appeared somewhat 
lower than coefficients of WG intake and sums of conjugates and free 
aglycones. However, the observed correlations were of the same magnitude for 
the individual conjugates. 
Rye, the richest source of AR, was the main component of WG intake and a 
major contributor to the intake of cereal fibre in paper V. Since the excretion of 
AR metabolites is well correlated to the intake of AR, the excretion of AR 
metabolites reflected the intake of fibre and WG, especially WG rye.  
Significant correlations between the intake of WG wheat and urinary 
metabolites were weak and in most cases absent. The intake of WG wheat was 
low, unstable and not correlated to that of WG rye, hence excretion was unable 
to reflect WG wheat intake. It is possible that the correlation is stronger in 
populations where rye intake is low and a stable intake of wheat constitutes a 
more predominant part of WG intake (Guyman et al., 2008). 52 
 
Figure 10. Relative validity of urinary alkylresorcinol metabolites estimated by calculation of 
Spearman’s rank correlation coefficient (rs) between self-reported intakes of whole grain (WG) 
and cereal fibre (estimated by 3DWFR) and urinary DHBA and DHPPA. Correlation coefficients 
were calculated between AR metabolite excretion and concurrent intake (grey), intake 2-3 months 
later (striped), mean intake on two occasions (dotted), and mean intake adjusted for intra-
individual variance (white). Error bars indicate 95% confidence intervals of rs. 
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Although AR metabolites in spot samples of morning urine correlated well 
with 24-h excretion, the lower reproducibility of AR metabolites in spot 
samples of morning urine resulted in weaker correlations to intake compared to 
24-h metabolite excretions. 
As expected, correlations were stronger when intake and excretion were 
measured concurrently compared to when measured separately 2-3 months 
apart. With the moderate reproducibility of the intake in paper V, it is likely 
that a single 3DWFR would be insufficient to estimate longer-term intake.  
The rs calculated between mean WG and fibre intakes and metabolite excretion 
(morning urine and 24-h) on the different occasions were significant. In order 
to provide a better estimate of the correlation between the ‘true’ intake 
(estimated by a currently non-available golden standard method) and 
metabolite excretion, adjusting the intake estimates for intra-individual 
variance resulted in increased rs, although 95% CI increased similarly as a 
consequence of the limited number of subjects and the instability of intake.  
This indicates, however, that both urine sample types reflect the medium-
term (2-3 months) intake of fibre (total and cereal) and WG (total, rye, and 
rye+wheat) among the 66 participants in paper V. Due to the similar 
reproducibility of intake and 24-h excretion, corrected rs between intake and 
24-h excretion were alike when adjusting for intake or biomarker variabilities. 
As a consequence of the lower reproducibility in morning urine, adjusting rs 
between intake and morning urine metabolite concentration for variances in 
biomarker measurement resulted in greater coefficients compared to when 
adjusting for intake variability.  
The relative validity of AR and their metabolites among free-living subjects 
has been assessed in different studies (Table 11). The methods for estimating 
intake differ between the studies and the highest correlations are found when 
intake estimation is as detailed as possible (i.e. weighed food records). Since 
AR metabolites mainly reflect short-term intake, correlations between long-
term intake assessment methods (e.g., FFQ) and biomarker measurements are 
weak unless the intake is stable over the period assessed. The cumulative 
nature of urine collections reduces the temporal impact of intake during the 
day, and thus offers greater possibilities for reflecting daily intake than 
measurements in plasma, which is highly time-dependent. 
In previous studies and in paper V, the self-reported intake of cereal fibre 
was correlated with AR metabolites in plasma and/or urine (Landberg et al., 
2012b; Aubertin-Leheudre et al., 2010a; Aubertin-Leheudre et al., 2008). This 
suggests that AR metabolites might be useful to reflect cereal fibre in 
populations where WG rye and wheat are major contributors of cereal fibre. 54 
Table 11. Correlations between self-reported intake and AR, DHBA, and DHPPA in biological samples from free-living subjects.   
 Sample  Subjects 
 Country 
 
N 
 
Females 
Intake 
estimation 
 
Parameter 
Correlation
1 Reference 
Alkylresorcinol Plasma  Switzerland 29 61%  3DWFR
2 Total  WG  0.57
c (Ross et al., 2009) 
 Plasma  Switzerland  29  61%  WG  FFQ
2 Total  WG  0.55
c (Ross et al., 2009) 
  Plasma  Sweden  51  80%  3DWFR  WG wheat & rye  0.53
c,3 (Andersson et al., 2011) 
 Plasma
4 Denmark 360  100% FFQ  Rye  bread  0.25
c (Landberg et al., 2011) 
DHBA
2 24-h  urine
5 Finland  60  100%  5WDFR
2 Rye  0.52
c (Aubertin-Leheudre et al., 2010c) 
 24-h  urine  Sweden  66  76%  3DWFR
2  WG wheat & rye  0.58
c,6 Paper  V 
 Spot  urine  Sweden  66  76%  3DWFR
2  WG wheat & rye  0.48
c,6 Paper  V 
 Plasma
7 Finland  60  100% 5WDFR
2 Rye  0.32
a (Aubertin-Leheudre et al., 2010c) 
 Spot  urine  USA  95  100%  FFQ  WG  0.16 
0.34
c 
(Landberg et al., 2012b) 
DHPPA
2 24-h  urine
5 Finland  60  100%  5WDFR
2 Rye  0.44
c (Aubertin-Leheudre et al., 2010c) 
 24-h  urine  Sweden  66  76%  3DWFR
2  WG wheat & rye  0.56
c,6 Paper  V 
 Spot  urine  Sweden  66  76%  3DWFR
2  WG wheat & rye  0.52
c,6 Paper  V 
 Plasma
7 Finland  60  100% 5WDFR
2 Rye  0.39
b (Aubertin-Leheudre et al., 2010c) 
 Spot  urine  USA  95  100%  FFQ  WG  0.16 
0.37
c 
(Landberg et al., 2012b) 
1 Significant levels of correlations are indicated by superscript letters: 
aP<0.05, 
bP<0.01, 
cP<0.001.
 23DWFR, 3-day weighed food record; 5DWFR, 5-day weighed food record; 
DHBA, 3,5-dihydroxybenzoic acid; DHPPA, 3-(3,5-dihydroxyphenyl)-propanoic acid; WG, whole grain; WG FFQ, Whole grain food frequency questionnaire. 
3Correlation between 
mean of two 3DWFR and two fasting plasma samples collected 2-3 months apart. 
4Non-fasting plasma samples. 
5Three consecutive 24-h collections were pooled before analysis. 
6Evaluated on two occasions (2-3 months apart) and only the lowest value is shown here. 
7Three consecutive plasma samples were pooled before analysis.
8Estimated on two occasions 
about 4 years apart. 55 
4.3.3  Potential use as biomarkers 
In epidemiology 
One aim of this thesis was to evaluate AR metabolites as biomarkers of whole 
grain wheat and rye to be used in observational studies. Akin to AR, a limiting 
factor for this purpose is the relatively low reproducibility of the metabolites 
observed (Table 10), which indicates that a single plasma or urine sample in 
many populations will be insufficient to estimate the ‘true’ biomarker 
concentration/excretion, which is related to habitual intake of WG rye and 
wheat. As for AR previously discussed, the reproducibility of AR metabolites 
is dependent on the intake stability of AR-containing foods, since the 
formation and elimination of DHBA and DHPPA are rather quick (Paper III) 
(Soderholm et al., 2011; Soderholm et al., 2009). A high reproducibility of AR 
metabolites is possible in populations with a stable WG intake, and would 
reduce the number of measurements required for a reliable estimation of ‘true’ 
long-term biomarker status. However, the reproducibility of WG intake under 
free-living conditions has never been reported to be more than moderate 
(Landberg et al., 2012b; Andersson et al., 2011). If urinary AR metabolites in 
single samples are to be used to reflect long-term intakes of WG or fibre, 
variance components of excretion should be reliably addressed in the 
population of interest in order to allow adjustment of risk estimates for intra-
individual variations. 
Urine samples offer a cumulative measurement of AR metabolites, in 
contrast to plasma samples which are more time-dependent. This, in 
combination with simple and unassisted sampling, promotes the use of urinary 
AR metabolites for the estimation of whole grain intake. Unfortunately, the 
sample type where AR metabolites display the highest reproducibility and 
validity (i.e., >12-h urine collections) is probably the least available in large 
observational studies.  
In addition, prospective cohort studies commonly offer non-fasting plasma 
samples. The reproducibility and validity of AR metabolites in non-fasting 
samples have so far not been assessed, although studies on AR suggest that this 
sample type would show lower reproducibility and validity compared to fasting 
samples (Andersson et al., 2011; Landberg et al., 2011). 
The combined plasma concentrations of AR and their metabolites might 
possess better reproducibility and validity than what they do individually, 
though this has not yet been evaluated. In order to investigate this, the method 
utilized in paper III should be optimized and validated, to enable the reliable 
and simultaneous quantification of AR and their metabolites in plasma. 56 
Recently, an alternative use of dietary biomarkers has been proposed, where 
biomarkers have been used in combination with traditional dietary assessment 
methods to improve intake estimations and to reduce sample requirements 
(Freedman et al., 2010a; Freedman et al., 2010b). This possible use of AR 
metabolites should be evaluated. 
In intervention studies 
Another potential use of AR metabolites as biomarkers of AR-containing foods 
is to assess compliance during dietary intervention studies. Previously plasma 
AR have been used for this purpose in one study, while similar applications of 
AR metabolites are still absent (Ross et al., 2011). Urinary AR metabolites 
might be advantageous to plasma AR as they may reflect AR intake better 
(Paper  V)(Andersson et al., 2011) and can be obtained by non-invasive 
sampling, which does not necessitate the involvement of medical professionals.  
One promising application of AR metabolites as biomarkers of compliance 
could be to monitor individual variations over the treatment periods. This has 
been proposed for plasma AR concentrations, which remained very stable 
during a 6-week rye intervention study (Landberg et al., 2009c).  
However, in order to estimate compliance from a single biomarker 
measurement, threshold values need to be established (Ross, 2012). 
Apparently, AR metabolites in plasma and urine can reflect AR intake at group 
level (Aubertin-Leheudre et al., 2010c; Landberg et al., 2009a). However, the 
large variations between and within individuals would be a hindrance in 
determining the compliance of single participants. In addition, AR metabolites 
have been identified in urine from celiac patients and there is some debate 
about whether they may be produced from foods other than WG wheat and rye. 
Therefore, more knowledge of alternative sources of DHPPA and DHBA is 
needed in order to evaluate the potential use of AR metabolites as DB.  
The reproducibility of plasma concentration and urinary excretion of AR 
metabolites under interventional conditions needs to be assessed before 
establishing them as biomarkers of compliance. Obviously, if they are to be 
used in intervention studies focusing on WG, the intake of bran needs to be 
controlled and vice versa. 
Validation of dietary assessment methods 
Apart from the aforementioned biomarker applications listed above AR 
metabolites could potentially be used to validate traditional dietary assessments 
methods, since the errors of the biomarker are likely to be independent from 
the errors of the traditional methods (e.g. FFQ). Several models utilizing 
biomarkers have been proposed for this purpose (Fraser et al., 2005; 57 
Spiegelman et al., 2005; Subar et al., 2003; Kaaks et al., 1997). However, the 
independence of errors between the different estimation instruments used in 
these validations may still be questioned (Rosner et al., 2008). For example, 
both food records and FFQ are based on self-reports, thus their measurement 
errors are not likely to be independent. Similarly, two biomarkers measured in 
urine would also share errors to some degree. 
 
In conclusion, since 24-h urine collections are scarcely available in 
epidemiological studies, the present body of evidence shows limited potential 
for single measurements of AR metabolites as a surrogate measurement of WG 
wheat and rye intake in large observational studies. This is mainly due to the 
inability of single samples to reflect long-term habitual WG intake. It is 
possible that repeated measurements could successfully reflect long-term 
intake. However, if AR metabolites are to be used as biomarkers in 
epidemiology it is strongly advised that variance components in the population 
of interest should be estimated to allow adjustments for intra-individual 
variation. Intake estimation based on combinations of biomarkers and 
traditional dietary assessment methods might offer a promising use of AR 
metabolites. As a cumulative measurement, urinary AR metabolites are likely 
to be advantageous compared to their plasma counterparts in terms of 
reproducibility, though sample availability might favour the use of plasma 
samples. Plasma and urinary AR metabolites might be useful as biomarkers of 
compliance in intervention studies, especially to monitor compliance within 
individuals over treatment periods. However, more information is needed on 
alternative sources of DHBA and DHPPA (unrelated to AR intake) and the 
normal range of AR metabolites in urine or plasma from subjects excluding 
WG and bran products of wheat and rye from their diets. Finally, urinary AR 
metabolites might be useful to validate traditional dietary assessment methods. 
Work on testing of the validity of plasma AR metabolites as biomarkers of 
wholegrain wheat and rye intake remains to be conducted. 
  58 
   59 
5 Main  findings 
  A precise and selective GC-MS method for the quantification of urinary AR 
metabolites was developed (I) and was adequately utilized to analyze a 
large number of samples.  
 
  A comparison of urinary AR metabolite concentrations quantified by GC-
MS and HPLC-CEAD resulted in small, but significant, differences (II). 
However, these differences can be considered as negligible in most cases. 
 
  The elimination of AR metabolites in rats was faster compared to their 
precursors and elimination half-lives increased with side chain length (III). 
There was no difference in the total amount of AR metabolites formed after 
ingestion of C17:0 and C25:0, indicating that both AR homologues were 
absorbed to a similar degree. 
 
  A substantial proportion of urinary AR metabolites (especially DHPPA) 
was found as conjugates, and glucuronides were the main conjugates (I, 
IV). Several potential determinants for urinary AR metabolites were 
identified and included both anthropometric and dietary factors, which 
might affect AR metabolism and thus the performance of AR metabolites as 
biomarkers (IV). 
 
  The reproducibility of AR metabolites in 24-h urine from free-living 
subjects was comparable to AR intake and plasma concentration, while it 
was lower in spot samples of morning urine (V).  
 
  The relative validity of urinary AR metabolites as biomarkers of WG wheat 
and rye was good (r>0.5) when assessed in both 24-h collections and spot 
samples (V). 
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6 Future  research 
  Faster and cheaper methods for the quantification of urinary AR 
metabolites (e.g., immunological and/or spectroscopic) are required in order 
to allow screening of large numbers of samples. 
 
  Instead of using AR and their metabolites individually, their sum might be 
advantageous as biomarkers for the intake of WG rye and wheat. However, 
further method development is needed for the reliable simultaneous 
quantification of AR and their metabolites in plasma.  
 
  The identification of AR metabolizing enzymes is desirable as it would 
increase the knowledge of AR metabolite formation and could aid the 
evaluation of genetic impact on biomarker performance. In addition it could 
help explain the actual mechanisms of the potential determinants of urinary 
AR metabolites. 
 
  Concentrations of AR metabolites in plasma and urine from individuals 
avoiding dietary AR should be quantified and alternative sources of DHBA 
and DHPPA should be identified.  
 
  The reproducibility of AR metabolites should be assessed under 
interventional conditions in order to evaluate their suitability as compliance 
biomarkers. 
 
  The potential use of AR metabolite measurements in combination with 
traditional dietary assessment methods for intake estimation should be 
evaluated. 
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